OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.510
-0.020 (-1.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed
OKYO Pharma Employees
OKYO Pharma had 3 employees as of March 31, 2024. The number of employees decreased by 5 or -62.50% compared to the previous year.
Employees
3
Change (1Y)
-5
Growth (1Y)
-62.50%
Revenue / Employee
n/a
Profits / Employee
-$3,562,623
Market Cap
51.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
OKYO News
- 27 days ago - OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod - GlobeNewsWire
- 3 months ago - OKYO Pharma Announces Chairman and CEO Acquire Shares - GlobeNewsWire
- 3 months ago - Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited - Accesswire
- 5 months ago - MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 6 months ago - OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain - GlobeNewsWire
- 8 months ago - OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 8 months ago - OKYO Pharma CEO Interview to Air on Bloomberg TV - GlobeNewsWire
- 8 months ago - OKYO Pharma Announces Chairman Acquires Shares - GlobeNewsWire